ClinicalTrials.gg
RecruitingNCT05998343SILUpdated Aug 18, 2023

Intergenerational Program for Social Isolation and Loneliness in Older Adults Discharged From the Emergency Department

An interventional study of Intergenerational HOW R U? and Same-Generation Peer Support HOW R U? in Social Isolation, Loneliness and Geriatric, sponsored by Mount Sinai Hospital, Canada. Recruiting at 1 site in Canada. Open to participants aged 70 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-18.

Sponsored by Mount Sinai Hospital, Canada · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2023, 3 years ago, but the record still lists the study as recruiting.
  • Registered 1 year 8 months after the study started (first participant enrolled Nov 2021, registered Jul 2023).
  • Started Nov 2021; still recruiting 5 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
141
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Social Isolation with a site in Canada — 9 open to participants now, 10 under way, none of them phase 3. Social Isolation · Canada.

Planned enrollment
11th of 29
141 · median 120
Started
2021
with 3 others
No phase
29 of 30
9 open now
Registered
23rd of 30
by date
Lead sponsor
2 of 30
Mount Sinai Hospital, Canada

Among the 30 studies in Social Isolation with a site in Canada, this one is the 11th largest by planned enrollment of the 29 interventional ones that give a count, is one of 4 that started in 2021, is one of 29 with no phase, and was the 23rd registered.

Social Isolation

237 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

Browse Social Isolation studies →

Open to participants now

9 of the 30 studies in Social Isolation with a site in Canada are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 34 Social Isolation studies recruiting now, 22 (65%) set no upper age limit and 6 (18%) stop at 75 or younger; 4 take children under 18; 18 take healthy volunteers.

This study: 70 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Social Isolation with a site in Canada, or all of them as a file.
02

Study summary

Social isolation and loneliness worsens older adults' risk of dementia, quality of life, and death as much as smoking. Older adults are more likely to use emergency services and are also more likely to experience social isolation and loneliness than younger people. The emergency department is a new setting to screen for social isolation and loneliness in older adults and help accordingly.

Social isolation and loneliness are experienced differently by different older adults. Different interventions combatting social isolation and loneliness may work better for different people, and little is known about older adult's preferences for specific types of interventions.

HOW R U? is an effective and feasible intervention using same-generation peer support offered by trained hospital volunteers to reduce social isolation and loneliness in older adults. In partnership with the Australian developer of HOW R U?, this study will compare an intergenerational HOW R U? intervention using younger volunteers with the same-generation peer support intervention and a waitlist control arm.

The investigators partnered with the staff of emergency departments and family medicine clinics to identify people who will benefit from an intervention combatting, and Volunteer Services to recruit volunteers.

The investigators hypothesize that the older adults who receive the intergenerational HOW R U? intervention will have a greater improvement in social isolation and loneliness.

Read the detailed description

Introduction:

Social isolation and loneliness (SIL) worsens mortality and other outcomes among older adults as much as smoking. The investigators previously tested the impact of the HOW R U? intervention using peer support from similar aged volunteers and demonstrated reduced SIL among older adults discharged from the Emergency Department (ED). Generativity, defined as "the interest in establishing and guiding the next generation" can provide an alternative theoretical basis for reducing SIL via intergenerational programs between members of younger and older generations. The current study will examine the impact of younger intergenerational volunteers providing the HOW R U? intervention. As part of a program of research following the Obesity-Related Behavioral Intervention Trials (ORBIT ) model, findings of this RCT will be used to define which intervention characteristics are most effective in reducing SIL. This trial builds on feasibility work conducted in the investigators' previous trial (NCT 05228782).

Methods and Analysis:

The investigators will compare the use of the same-generation peer support HOW RU? intervention to support by intergenerational volunteers. The investigators will use a common wait list control group in this three-arm randomized controlled trial (RCT).

Trained volunteers will deliver 12 weekly telephone support calls. The investigators will recruit 141 participants ≥70 years of age with baseline loneliness (six-item De Jong loneliness score of 2 or greater) from two EDs. Research staff will assess change in loneliness (De Jong Loneliness Scale), social isolation (Lubben's Social Network Scale), depression (Geriatric Depression Score), quality of life (EQ-5D-5L), functional status (Older Americans Resource Scale), generativity (Loyola Generativity Scale), and perceived benefit at baseline (subjective Likert scale), at 12-14 weeks, and 24-26 weeks post-intervention. The study will follow the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines.

Ethics and Dissemination:

The participating research ethics boards have granted ethics approval, and the participants randomized to the waitlist control group will be offered their choice of intergenerational or same-generation HOW R U? interventions after 12 weeks. Results will be shared through journal publications, conference presentations, social media, and through the International Federation of Emergency Medicine.

03

Conditions studied

  • Social Isolation
  • Loneliness
  • Geriatric

Keywords

  • Loneliness
  • Social Isolation
  • Emergency Department
  • Geriatrics
  • Geriatric Psychiatry
  • Family Medicine
  • Randomized Clinical Trial
04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any community-dwelling person 70 years of age and older receiving care from the ED, Family Medicine, or Geriatric clinics at the two participating sites (MSH and NYGH) will be eligible.
  • Baseline de Jong loneliness scores of 2.0 will be required for participation in the trial.

Exclusion criteria

Exclusion Criteria:

  • Age less than 70 years;
  • Patients with communication problems (critically ill, unconscious, language barrier, speech impairment or otherwise unable to provide consent), or admission to a hospital for > 72 hours.
  • Patients with severe cognitive impairment or those living in nursing homes who are dependent on others for their activity of daily living will be excluded.
  • Patients without any mobile phone or landline.

Volunteers:

  • Volunteers will be 60 years of age or older to qualify as peer-support volunteers.
  • Volunteers will be 19-39 years of age to qualify as intergenerational volunteers.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
141 participants (estimated)

Study arms

  • Experimental
    HOW R U? intervention delivered by same-generation peer volunteer

    HOW R U?

    Behavioral: Same-Generation Peer Support HOW R U?

  • Experimental
    HOW R U? intervention delivered by intergenerational volunteer

    Behavioral: Intergenerational HOW R U?

  • No intervention
    Waitlist control group

    After the primary outcome assessment at 12 weeks, control group participants will be offered HOW R U? intervention support outside of the main trial. They will be allowed to choose either intergenerational or same-generation versions.

Interventions

  • BehavioralIntergenerational HOW R U?

    1-on-1 discussion over telephone with a trained volunteer aged 19-39 years old who has received training to provide strength-based support sessions weekly for 12 weeks.

  • BehavioralSame-Generation Peer Support HOW R U?

    1-on-1 discussion over telephone with a trained volunteer aged 60 years or older who has received training to provide strength-based support sessions weekly for 12 weeks.

06

What researchers measure

Primary outcomes

  1. Change in loneliness using De Jong Gierveld 6-item Loneliness Scale from Baseline to 12 Weeks

    The minimum value is 0 and the maximum value is 6, with the higher value corresponding with a greater degree of loneliness. It is divided into 4 clinically relevant categories: 0-1 = no loneliness, 2-3 = low levels of loneliness, 4-5 = moderate to severe loneliness, and 6 = severe loneliness.

    Time frame: Measure at baseline, at 12 weeks (primary outcome) and 24 weeks (sustainability)

Secondary outcomes

  1. Change in perceived social support using Lubben Social Network Scale

    The Lubben Social Network Scale is a measure of perceived social support received from the family and friends and consists of 6 items each of which is scored from 0 to 5: none = 0, one = 1, two = 2, three or four = 3, five through eight = 4, nine or more = 5. The total score ranges from 0 to 30, and a score of 12 and lower indicates a status of "at-risk" for social isolation

    Time frame: Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  2. Change in mood using Geriatric Depression Scale

    The Geriatric Depression Scale is a 15-item scale of mood that is extensively validated in older populations to screen for depression. Scores range from 0 to 15. A score of 0-4 is considered normal, and a score of 5 or higher is considered indicative of depression with higher scores indicating higher severity of depression.

    Time frame: Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  3. Change in Quality of Life using Euro-Qual 5 Dimensions 5 Levels

    EQ-5D-5Lin 5 dimensions. In each dimension, quality of life can be measured from 1 (best quality of life) to 5 (worst quality of life), giving a possible score of 5-25. A higher score indicates worse quality of life. (Euro-Qual 5 Dimensions 5 Levels) scale assesses quality of life

    Time frame: Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  4. Change in Functional Status using Older Americans Resource Scale

    The Older Americans Resource Scale (OARS) consists of 7 activities of daily living (ADL) questions and 7 instrumental activities of daily living (IADL) all rated as "without any help" (2 points), "with some help" (1 point), or "completely unable" (0 points). The ADL and IADL scores can be used separately or combined to produce an overall OARS score from 0-28.

    Time frame: Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  5. Change in self-perceptions of generativity using Loyola Generativity Scale

    The Loyola Generativity Scale is a 20-item scale with each question answered 0 = statement never applies to you, 1 = statement only occasionally or seldom applies to you, 2 = statement applies to you fairly often, or 3 = statement applies to you very often or nearly always. The higher the score, the greater the sense of generativity.

    Time frame: Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  6. Perceived benefit to participant at 12 weeks

    Perceived benefit by the participant pre- and post-intervention will be assessed using the question "Compared to working with a volunteer around the same age as you, you think that working with a younger volunteer is:" followed by a 5-point Likert scale with the following options: A lot less helpful for me, a little less helpful for me, about the same for me, a little more helpful for me, or a lot more helpful for me.

    Time frame: Measure at baseline, at 12 weeks and 24 weeks (sustainability)

  7. Perceived benefit to volunteer at 12 weeks

    Perceived benefit by the participant for the volunteer pre- and post-intervention will be assessed using the question "Compared to working with a volunteer around the same age as you, you think that working with a younger volunteer is:" followed by a 5-point Likert scale with the following options: A lot less helpful for the volunteer, a little less helpful for the volunteer, about the same for the volunteer, a little more helpful for the volunteer, or a lot more helpful for volunteer.

    Time frame: Measure at baseline, at 12 weeks and 24 weeks (sustainability)

Other outcomes

  1. Feasibility and Process Outcome 1 - Participant preference

    To assess for participant preference for same-generation peer support versus intergenerational HOW R U? intervention, we will use a 5-point Likert scale with the following options: "I strongly prefer peer support", "I prefer peer support", "neutral", "I prefer intergenerational" and "I strongly prefer intergenerational".

    Time frame: Measure at 12 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The de-identified individual level data that support the findings of this study will be available on reasonable request from the Principal Investigator Dr. Jacques Lee (Jacques.lee@sinaihealth.ca) to improve scientific transparency, verify the study findings and generating new knowledge. As this research was supported by public funding, request for commercial purposes will require approval of the funding agency.

Time frame: 18 months from study completion

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2021 (actual). Primary completion is estimated for Nov 2023, 24 months after the start.

Of 156 non-industry interventional studies with no phase under Social Isolation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's planned 24 months is above that.

Counting every sponsor, half of 157 studies reached it within 18 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2023
First posted
Aug 18, 2023
StartActual
Nov 1, 2021
Primary completionEst.
Nov 1, 2023
CompletionEst.
Feb 1, 2024
Last update
Aug 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05998343
Collaborators
North York General Hospital, Sunnybrook Research Institute, University of Toronto, Bolton Clarke Research Institute, King's College London
Responsible party
Sponsor
First posted
Aug 18, 2023
Start date
Nov 1, 2021
Primary completion
Nov 1, 2023 (estimated)
Completion
Feb 1, 2024 (estimated)
Last update
Aug 18, 2023

Study contacts

Jacques Lee, MD
Contact
Jacques.lee@sinaihealth.ca
4168771447
David Zheng, MD
Contact
dzheng33@uwo.ca
5199335838

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion